PortfoliosLab logoPortfoliosLab logo
VEEV vs. TDOC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VEEV vs. TDOC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Veeva Systems Inc. (VEEV) and Teladoc Health, Inc. (TDOC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VEEV achieves a -25.08% return, which is significantly lower than TDOC's 1.14% return. Over the past 10 years, VEEV has outperformed TDOC with an annualized return of 17.25%, while TDOC has yielded a comparatively lower -5.55% annualized return.


VEEV

1D
-3.11%
1M
0.54%
YTD
-25.08%
6M
-30.04%
1Y
-41.39%
3Y*
-3.76%
5Y*
-10.46%
10Y*
17.25%

TDOC

1D
0.43%
1M
-2.34%
YTD
1.14%
6M
-6.35%
1Y
-2.61%
3Y*
-33.25%
5Y*
-45.73%
10Y*
-5.55%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VEEV vs. TDOC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
VEEV
Veeva Systems Inc.
-25.08%6.17%9.21%19.30%-36.83%-6.16%93.55%57.48%61.58%35.82%
TDOC
Teladoc Health, Inc.
1.14%-22.99%-57.82%-8.88%-74.24%-54.08%138.84%68.89%42.24%111.21%

Correlation

The correlation between VEEV and TDOC is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.36

Correlation (3Y)
Calculated over the trailing 3-year period

0.40

Correlation (5Y)
Calculated over the trailing 5-year period

0.53

Correlation (10Y)
Calculated over the trailing 10-year period

0.51

Correlation (All Time)
Calculated using the full available price history since Jul 1, 2015

0.49

The correlation between VEEV and TDOC shifts across timeframes, from 0.36 (1 year) to 0.53 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

VEEV:

$27.76B

TDOC:

$1.27B

EPS

VEEV:

$5.63

TDOC:

-$0.97

PS Ratio

VEEV:

8.43

TDOC:

0.50

PB Ratio

VEEV:

3.80

TDOC:

0.95

Total Revenue (TTM)

VEEV:

$3.32B

TDOC:

$2.51B

Gross Profit (TTM)

VEEV:

$2.49B

TDOC:

$1.74B

EBITDA (TTM)

VEEV:

$1.00B

TDOC:

-$43.17M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VEEV vs. TDOC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VEEV
VEEV Risk / Return Rank: 66
Overall Rank
VEEV Sharpe Ratio Rank: 22
Sharpe Ratio Rank
VEEV Sortino Ratio Rank: 44
Sortino Ratio Rank
VEEV Omega Ratio Rank: 55
Omega Ratio Rank
VEEV Calmar Ratio Rank: 1010
Calmar Ratio Rank
VEEV Martin Ratio Rank: 66
Martin Ratio Rank

TDOC
TDOC Risk / Return Rank: 4040
Overall Rank
TDOC Sharpe Ratio Rank: 4040
Sharpe Ratio Rank
TDOC Sortino Ratio Rank: 4141
Sortino Ratio Rank
TDOC Omega Ratio Rank: 3939
Omega Ratio Rank
TDOC Calmar Ratio Rank: 4141
Calmar Ratio Rank
TDOC Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VEEV vs. TDOC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Veeva Systems Inc. (VEEV) and Teladoc Health, Inc. (TDOC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VEEVTDOCDifference
Sharpe ratioReturn per unit of total volatility

-1.11

Sortino ratioReturn per unit of downside risk

-2.14

Omega ratioGain probability vs. loss probability

0.79

1.04

-0.25

Calmar ratioReturn relative to maximum drawdown

-0.82

-0.05

-0.77

Martin ratioReturn relative to average drawdown

-1.47

-0.09

-1.38

VEEV vs. TDOC - Sharpe Ratio Comparison

The current VEEV Sharpe Ratio is -1.16, which is lower than the TDOC Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of VEEV and TDOC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


VEEVTDOCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.16

-0.04

-1.11

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.28

-0.72

+0.44

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.45

-0.09

+0.55

Sharpe Ratio (All Time)

Calculated using the full available price history

0.32

-0.20

+0.51

Drawdowns

VEEV vs. TDOC - Drawdown Comparison

The maximum VEEV drawdown since its inception was -61.35%, smaller than the maximum TDOC drawdown of -98.48%. Use the drawdown chart below to compare losses from any high point for VEEV and TDOC.


Loading charts...

Drawdown Indicators


VEEVTDOCDifference

Max Drawdown

Largest peak-to-trough decline

-61.35%

-98.48%

+37.13%

Max Drawdown (1Y)

Largest decline over 1 year

-50.55%

-52.75%

+2.20%

Max Drawdown (3Y)

Largest decline over 3 years

-50.55%

-84.98%

+34.43%

Max Drawdown (5Y)

Largest decline over 5 years

-55.69%

-97.39%

+41.70%

Max Drawdown (10Y)

Largest decline over 10 years

-55.69%

-98.48%

+42.79%

Current Drawdown

Current decline from peak

-50.96%

-97.60%

+46.64%

Average Drawdown

Average peak-to-trough decline

-26.05%

-54.19%

+28.14%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.16%

27.72%

+0.44%

Volatility

VEEV vs. TDOC - Volatility Comparison

The current volatility for Veeva Systems Inc. (VEEV) is 14.68%, while Teladoc Health, Inc. (TDOC) has a volatility of 19.39%. This indicates that VEEV experiences smaller price fluctuations and is considered to be less risky than TDOC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VEEVTDOCDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.68%

19.39%

-4.71%

Volatility (6M)

Calculated over the trailing 6-month period

29.31%

39.18%

-9.87%

Volatility (1Y)

Calculated over the trailing 1-year period

35.89%

58.60%

-22.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.98%

63.70%

-25.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

38.24%

60.39%

-22.15%

Dividends

VEEV vs. TDOC - Dividend Comparison

Neither VEEV nor TDOC has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

VEEV vs. TDOC - Financials Comparison

This section allows you to compare key financial metrics between Veeva Systems Inc. and Teladoc Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


400.00M500.00M600.00M700.00M800.00M900.00M20222023202420252026
882.95M
613.85M
(VEEV) Total Revenue
(TDOC) Total Revenue
Values in USD except per share items

VEEV vs. TDOC - Profitability Comparison

The chart below illustrates the profitability comparison between Veeva Systems Inc. and Teladoc Health, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

66.0%68.0%70.0%72.0%74.0%76.0%78.0%20222023202420252026
74.7%
67.8%
Portfolio components
VEEV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Veeva Systems Inc. reported a gross profit of 659.69M and revenue of 882.95M. Therefore, the gross margin over that period was 74.7%.

TDOC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teladoc Health, Inc. reported a gross profit of 416.32M and revenue of 613.85M. Therefore, the gross margin over that period was 67.8%.

VEEV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Veeva Systems Inc. reported an operating income of 273.11M and revenue of 882.95M, resulting in an operating margin of 30.9%.

TDOC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teladoc Health, Inc. reported an operating income of -61.77M and revenue of 613.85M, resulting in an operating margin of -10.1%.

VEEV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Veeva Systems Inc. reported a net income of 260.94M and revenue of 882.95M, resulting in a net margin of 29.6%.

TDOC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teladoc Health, Inc. reported a net income of -63.84M and revenue of 613.85M, resulting in a net margin of -10.4%.


Frequently Asked Questions


VEEV and TDOC have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TDOC has higher volatility (19.39%) compared to VEEV (14.68%). In terms of maximum drawdown, VEEV dropped -61.35% vs TDOC's -98.48%.

TDOC currently has the higher Sharpe Ratio (-0.04 vs -1.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VEEV and TDOC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer